We encourage companies
that project change



News & events

Caixa Capital Risc leads sale of Sanifit Therapeutics to Vifor Pharma with upfront payment of €205M


• Largest acquisition in history of Spanish biotechnology sector and largest operation to date for Caixa Capital Risc • Holding 20% of the capital, Caixa Capital Risc is Sanifit’s biggest stakeholder and has supported company since 2006, participating in all financing rounds for a total investment of over €23M

Continue reading...

Other news See all news »